Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-21-015782
Filing Date
2021-05-04
Accepted
2021-05-04 17:26:04
Documents
12
Period of Report
2021-04-28
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A nt10023917x5_8ka.htm   iXBRL 8-K/A 77384
  Complete submission text file 0001140361-21-015782.txt   223974

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210428.xsd EX-101.SCH 3917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210428_lab.xml EX-101.LAB 23289
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210428_pre.xml EX-101.PRE 16546
5 EXTRACTED XBRL INSTANCE DOCUMENT nt10023917x5_8ka_htm.xml XML 4224
Mailing Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2
Business Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38594 | Film No.: 21890005
SIC: 2833 Medicinal Chemicals & Botanical Products